Founded in 1896 and headquartered in Basel, Switzerland, Roche is a global pioneer in healthcare, operating through two main divisions: Pharmaceuticals and Diagnostics. It is the world’s largest biotech company and a global leader in in-vitro diagnostics, particularly for cancer, neuroscience, immunology, and ophthalmology.
Roche is a frontrunner in Personalized Healthcare, integrating its diagnostic and pharmaceutical capabilities to tailor treatments to individual patients. By acquiring Genentech and Chugai, it solidified its dominance in biologics. In 2025, the company reported strong sales of 61.5 billion CHF, driven by blockbusters like Ocrevus, Hemlibra, and Vabysmo, and continues to be the industry’s top investor in research and development.
Here are some articles to give you a basic understanding of the company:
Roche – background and history
Below is a list of articles for the company:
-
Roche – 2025Q3 report
1. Group Performance & Financial Outlook 2. Pharmaceuticals Division (77.5% of Revenue) 3. Diagnostics Division (22.5% of Revenue) 4. R&D Milestones & Pipeline Progress 5. Regional Sales Highlights This income statement summary for the first nine months of 2025 (9M 2025) is based on the Roche Quarterly Statement. 9M 2025 Income Statement Summary (Sales Focus)…
-
Roche – History and Competitions
Roche’s history is characterized by its transformation from a small chemical factory into a global leader in personalized healthcare. Here is the chronological evolution of the company: 1. Founding and Early Globalization (1896–1919) Fritz Hoffmann-La Roche founded the company in Basel, Switzerland, during the Industrial Revolution. He was a visionary who believed that the future…